+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Supportive Care - Global Market Trajectory & Analytics

  • ID: 5139745
  • Report
  • September 2020
  • Region: Global
  • 140 pages
  • Global Industry Analysts, Inc
1 of 2
Global Cancer Supportive Care Market to Reach $24.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Cancer Supportive Care estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$24.6 Billion by 2027, growing at a CAGR of 1.8% over the analysis period 2020-2027. G-CSFs, one of the segments analyzed in the report, is projected to record a 1.3% CAGR and reach US$5.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bisphosphonates segment is readjusted to a revised 2.2% CAGR for the next 7-year period.

The U. S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 1.5% CAGR

The Cancer Supportive Care market in the U. S. is estimated at US$6.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2027 trailing a CAGR of 1.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.7% and 1.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Antiemetics Segment to Record 2.4% CAGR

In the global Antiemetics segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.8 Billion by the year 2027. We bring years of research experience to this 6th edition of our report. The 140-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Amgen, Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Tesaro, Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Cancer Supportive Care Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Cancer Supportive Care Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Cancer Supportive Care Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Cancer Supportive Care Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: G-CSFs (Therapeutic Class) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: G-CSFs (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: G-CSFs (Therapeutic Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Bisphosphonates (Therapeutic Class) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Bisphosphonates (Therapeutic Class) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Bisphosphonates (Therapeutic Class) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Antiemetics (Therapeutic Class) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Antiemetics (Therapeutic Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Antiemetics (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Opioids (Therapeutic Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Opioids (Therapeutic Class) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Opioids (Therapeutic Class) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: NSAIDs (Therapeutic Class) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: NSAIDs (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: NSAIDs (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: ESAs (Therapeutic Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 20: ESAs (Therapeutic Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 21: ESAs (Therapeutic Class) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Cancer Supportive Care Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 22: United States Cancer Supportive Care Market Estimates and Projections in US$ Million by Therapeutic Class: 2020 to 2027
  • TABLE 23: Cancer Supportive Care Market in the United States by Therapeutic Class: A Historic Review in US$ Million for 2012-2019
  • TABLE 24: United States Cancer Supportive Care Market Share Breakdown by Therapeutic Class: 2012 VS 2020 VS 2027
CANADA
  • TABLE 25: Canadian Cancer Supportive Care Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2020 to 2027
  • TABLE 26: Canadian Cancer Supportive Care Historic Market Review by Therapeutic Class in US$ Million: 2012-2019
  • TABLE 27: Cancer Supportive Care Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Class for 2012, 2020, and 2027
JAPAN
  • TABLE 28: Japanese Market for Cancer Supportive Care: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2020-2027
  • TABLE 29: Cancer Supportive Care Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2012-2019
  • TABLE 30: Japanese Cancer Supportive Care Market Share Analysis by Therapeutic Class: 2012 VS 2020 VS 2027
CHINA
  • TABLE 31: Chinese Cancer Supportive Care Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2020-2027
  • TABLE 32: Cancer Supportive Care Historic Market Analysis in China in US$ Million by Therapeutic Class: 2012-2019
  • TABLE 33: Chinese Cancer Supportive Care Market by Therapeutic Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
  • Market Facts & Figures
  • European Cancer Supportive Care Market: Competitor Market Share Scenario (in %)for 2019 & 2025
  • Market Analytics
  • TABLE 34: European Cancer Supportive Care Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 35: Cancer Supportive Care Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 36: European Cancer Supportive Care Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 37: European Cancer Supportive Care Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2020-2027
  • TABLE 38: Cancer Supportive Care Market in Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2012-2019
  • TABLE 39: European Cancer Supportive Care Market Share Breakdown by Therapeutic Class: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 40: Cancer Supportive Care Market in France by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 41: French Cancer Supportive Care Historic Market Scenario in US$ Million by Therapeutic Class: 2012-2019
  • TABLE 42: French Cancer Supportive Care Market Share Analysis by Therapeutic Class: 2012 VS 2020 VS 2027
GERMANY
  • TABLE 43: Cancer Supportive Care Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2020-2027
  • TABLE 44: German Cancer Supportive Care Historic Market Analysis in US$ Million by Therapeutic Class: 2012-2019
  • TABLE 45: German Cancer Supportive Care Market Share Breakdown by Therapeutic Class: 2012 VS 2020 VS 2027
ITALY
  • TABLE 46: Italian Cancer Supportive Care Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2020-2027
  • TABLE 47: Cancer Supportive Care Historic Market Analysis in Italy in US$ Million by Therapeutic Class: 2012-2019
  • TABLE 48: Italian Cancer Supportive Care Market by Therapeutic Class: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
  • TABLE 49: United Kingdom Market for Cancer Supportive Care: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2020-2027
  • TABLE 50: Cancer Supportive Care Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2012-2019
  • TABLE 51: United Kingdom Cancer Supportive Care Market Share Analysis by Therapeutic Class: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 52: Rest of Europe Cancer Supportive Care Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2020-2027
  • TABLE 53: Cancer Supportive Care Market in Rest of Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2012-2019
  • TABLE 54: Rest of Europe Cancer Supportive Care Market Share Breakdown by Therapeutic Class: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 55: Cancer Supportive Care Market in Asia-Pacific by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 56: Asia-Pacific Cancer Supportive Care Historic Market Scenario in US$ Million by Therapeutic Class: 2012-2019
  • TABLE 57: Asia-Pacific Cancer Supportive Care Market Share Analysis by Therapeutic Class: 2012 VS 2020 VS 2027
REST OF WORLD
  • TABLE 58: Rest of World Cancer Supportive Care Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2020 to 2027
  • TABLE 59: Rest of World Cancer Supportive Care Historic Market Review by Therapeutic Class in US$ Million: 2012-2019
  • TABLE 60: Cancer Supportive Care Market in Rest of World: Percentage Share Breakdown of Sales by Therapeutic Class for 2012, 2020, and 2027
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll